Note 14 - Subsequent Event

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Subsequent Events [Text Block]

(14) Subsequent Event

On October 7, 2016, the Company acquired 100% of PharmaCore Inc., a privately-owned company in High Point, North Carolina, for approximately $25,000. PharmaCore, which has been renamed Cambrex High Point, specializes in developing, manufacturing and scaling up small molecule APIs for clinical phase projects.

The Company does not expect the impact of its ownership in Cambrex High Point to be material to Cambrex’s income statement for 2016. Costs related to this acquisition are recorded on the Company’s income statement under the caption “Selling, general, and administrative expenses” and totaled $430 for the three and nine months ended September 30, 2016.